ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
11
views
0
references
Top references
cited by
11
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,427
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Determinants for successful marketing authorisation of orphan medicinal products in the EU
Author(s):
Michelle Putzeist
,
Harald E. Heemstra
,
Jordi Garcia
,
Aukje Mantel-Teeuwisse
,
Christine C Gispen-de Wied
,
Arno Hoes
,
Hubert Leufkens
Publication date:
2012-04-01
Journal:
Drug Discovery Today
Publisher:
Elsevier BV
Read this article at
ScienceOpen
Publisher
PubMed
Further versions
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Algerian Journal of Natural Products
Author and article information
Journal
DOI::
10.1016/j.drudis.2011.10.027
PubMed ID::
22094244
License:
https://www.elsevier.com/tdm/userlicense/1.0/
Data availability:
Comments
Comment on this article
Sign in to comment
Related Documents Log
scite_
Similar content
2,427
Scientific Opinion on application EFSA ‐ GMO ‐ BE ‐2013‐118 for authorisation of genetically modified maize MON 87427 × MON 89034 × 1507 × MON 88017 × 59122 and subcombinations independently of their origin, for food and feed uses, import and processing submitted under Regulation ( EC ) No 1829/2003 by Monsanto Company
Authors:
Hanspeter Naegeli
,
Andrew Nicholas E. Birch
,
Josep Maria Casacuberta
…
Assessment of the feed additives thiamine hydrochloride (3a820) and thiamine mononitrate (3a821) (vitamin B
1
) for all animal species for the renewal of their authorisation (Kaesler Nutrition GmbH)
Authors:
Roberto Edoardo Villa
,
Giovanna Azimonti
,
Eleftherios Bonos
…
Refusal of the marketing authorisation for Leqembi (lecanemab)
Authors:
See all similar
Cited by
11
A comparison of interventional clinical trials in rare versus non-rare diseases: an analysis of ClinicalTrials.gov
Authors:
Stuart Bell
,
Catrin Tudur-Smith
Mitigating Deficiencies in Evidence during Regulatory Assessments of Advanced Therapies: A Comparative Study with Other Biologicals
Authors:
Magdi Elsallab
,
Christopher Bravery
,
Andreas Kurtz
…
Systematic review of available evidence on 11 high-priced inpatient orphan drugs
Authors:
Tim A Kanters
,
Caroline de Sonneville-Koedoot
,
W Redekop
…
See all cited by
Version 1
- Current
Version 1